focus -WSS

focus

author：leisure time 2025-09-28 01:37:59 - browse：61

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb said that it would purchase Mirati Therapeutics, maker of the cancer drug Krazati, for $4.8 billion in cash in a deal that shows the continued interest of large pharmaceutical firms in relatively small “bolt-on” acquisitions.

Bristol said that it would pay $58.00 per share for Mirati, and would hold another $12.00 per share, or a total of $1 billion, to be paid if one of two different applications for an additional use for Krazati is approved within seven years after the merger closes.

Chris Boerner, Bristol’s chief operating officer and CEO-elect, said in a statement that Mirati had several cancer drugs in development that could deliver sales in the latter half of the decade and beyond, when investors worry that Bristol will need new products to sustain its growth.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Cue Health's Covid

hotspot

leisure time

WSS

FTC falls short on scrutinizing hospital mergers, study says

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Study suggests Covid rebound is far more common with Paxlovid than without

First transplant of an entire human eye performed

Exact Sciences stock tumbles despite strong cancer detection sales

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

explore

focus

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

Key Senate committee drafts bipartisan bill to stem drug shortages

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Why does health care cost so much? A reading guide

How to save PrEP access — and even expand it

UnitedHealth financials solid despite Change Healthcare cyberattack

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Tori Bowie and the unacceptable rates of Black maternal death

More tobacco lobbyists active in statehouses

focus

Cancer researcher Catriona Jamieson is sending tumors into space

What health policies could hitch a ride on a spending bill?

Q&A: Jennifer Adair on making gene therapy available globally

Experimental asthma app from Apple and Anthem shows promise

Cancer researcher Catriona Jamieson is sending tumors into space

Readout Newsletter: Zepbound, Valneva's vaccine, and more

hotspot

leisure time

leisure time

hotspot